Patients on hemodialysis who use opioids concurrently with a short-acting benzodiazepine are especially at risk for early death, a study found.
In a study, researchers identified 7 chemicals associated with an increased risk for chronic kidney disease.
Like many of my colleagues, I was very saddened to hear of the passing of Dr Burton “Bud” Rose on April 24, 2020 at the age of 77 years. There were two important sides of Dr Rose: First, he was well known in the nephrology community as an extremely modest, brilliant nephrologist who published 2…
Shaminder Gupta, MD, is a nephrologist who practices in Houma, Louisiana. He serves as the section chief at his hospital and also as Corporate Medical Director at Monogram Health, a renal disease care management company. He tells Renal & Urology News how he developed and manages a home dialysis program in which approximately 40% of his patients…
Compared with individuals with chronic metabolic syndrome (MetS), those who recovered from preexisting MetS had significant 16% decreased odds of chronic kidney disease, a study found.
Highly ranked outcomes for patients and caregivers include kidney function, survival, but also fatigue.
Horizon Therapeutics announced the availability of Procysbi (cysteamine bitartrate) delayed-release oral granules in tear-open packets for the treatment of nephropathic cystinosis in patients aged 1 year and older.
The authors of a recent editorial present a case for considering twice-weekly rather than the standard thrice-week hemodialysis, a shift that can reduce exposure to the COVID-19 coronavirus, conserve personal protective equipment and other benefits.
Compared with nonsteroidal anti-inflammatory drugs, opioids are more likely to result in adverse kidney outcomes and death, a study found.
A recent meta-analysis found a significant 13% decreased risk of incident chronic kidney disease among coffee drinkers compared with nondrinkers.